Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis

Neurology: Neuroimmunology and NeuroInflammation

Volumn 4, Issue 4, 2017, Pages

  Probasco, John C ^a,b   Solnes, Lilja ^c   Nalluri, Abhinav ^a   Cohen, Jesse ^a   Jones, Krystyna M ^c   Zan, Elcin ^c   Javadi, Mehrbod S ^c   Venkatesan, Arun ^a  

^a Johns Hopkins Encephalitis Center   (United States)

^b Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; COLLAPSIN RESPONSE MEDIATOR PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HU ANTIBODY; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; ALLERGIC ENCEPHALITIS; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; CLINICAL STUDY; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; SERUM; STEREOTACTIC PROCEDURE; TERTIARY CARE CENTER;

EID: 85025117585     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000352     Document Type: Article

References (31)

1. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:391-404.
2. Ances BM, Vitaliani R, Taylor RA, et al. Treatmentresponsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005;128: 1764-1777.
3. Fisher RE, Patel NR, Lai EC, Schulz PE. Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Clin Nucl Med 2012;37:e213-e218.
4. Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 2013;260:2744-2753.
5. Masangkay N, Basu S, Moghbel M, Kwee T, Alavi A. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. Nucl Med Commun 2014;35: 1038-1046.
6. Aupy J, Collongues N, Blanc F, Tranchant C, Hirsch E, De Seze J. Autoimmune encephalitis, clinical, radiological and immunological data [in French]. Rev Neurol [Paris] 2013;169:142-153.
7. Morbelli S, Djekidel M, Hesse S, Pagani M, Barthel H. Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:1009-1010.
8. Leypoldt F, Buchert R, Kleiter I, et al. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-Daspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry 2012;83:681-686.
9. Wegner F, Wilke F, Raab P, et al. Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography. BMC Neurol 2014;14:136.
10. Lagarde S, Lepine A, Caietta E, et al. Cerebral (18)FluoroDeoxy-Glucose Positron Emission Tomography in paediatric anti N-methyl-d-aspartate receptor encephalitis: A case series. Brain Dev 2016;38:461-470.
11. Yuan J, Guan H, Zhou X, et al. Changing brain metabolism patterns in patients with ANMDARE: serial 18F-FDG PET/CT findings. Clin Nucl Med 2016;41:366-370.
12. Chen Y, Xing XW, Zhang JT, et al. Autoimmune encephalitis mimicking sporadic Creutzfeldt-Jakob disease: A retrospective study. J Neuroimmunol 2016;295-296:1-8.
13. Lee BY, Newberg AB, Liebeskind DS, Kung J, Alavi A. FDG-PET findings in patients with suspected encephalitis. Clin Nucl Med 2004;29:620-625.
14. Kim TJ, Lee ST, Shin JW, et al. Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis. J Neuroimmunol 2014;270:45-50.
15. Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 2013;265:75-81.
16. Newey CR, Sarwal A, Hantus S. [(18)F]-Fluoro-deoxyglucose positron emission tomography scan should be obtained early in cases of autoimmune encephalitis. Autoimmune Dis 2016;2016:9450452.
17. Lee EM, Kang JK, Oh JS, Kim JS, Shin YW, Kim CY. 18F-Fluorodeoxyglucose positron-emission tomography findings with anti-N-methyl-d-aspartate receptor encephalitis that showed variable degrees of catatonia: three cases report. J Epilepsy Res 2014;4:69-73.
18. Novy J, Allenbach G, Bien CG, Guedj E, Prior JO, Rossetti AO. FDG-PET hyperactivity pattern in anti-NMDAr encephalitis. J Neuroimmunol 2016;297:156-158.
19. Fulham MJ, Brunetti A, Aloj L, Raman R, Dwyer AJ, Di Chiro G. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. J Neurosurg 1995;83:657-664.
20. Matheja P, Weckesser M, Debus O, et al. Drug-induced changes in cerebral glucose consumption in bifrontal epilepsy. Epilepsia 2000;41:588-593.
21. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using threedimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248.
22. Josephs KA, Duffy JR, Strand EA, et al. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 2012;135:1522-1536.
23. Dalmau J, Lancaster E,Martinez-Hernandez E, RosenfeldMR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
24. Graus F, Dalmau J. Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis-Authors' reply. Lancet Neurol 2016;15:1010.
25. Buck AK, Herrmann K, Stargardt T, Dechow T, Krause BJ, Schreyogg J. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J Nucl Med Technol 2010;38:6-17.
26. McKeon A, Apiwattanakul M, Lachance DH, et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol 2010;67:322-329.
27. Flanagan EP, McKeon A, Lennon VA, et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clinic Proc 2010;85:881-897.
28. Foster NL, Heidebrink JL, Clark CM, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 2007;130: 2616-2635.
29. Wong KK, Tolia B, Bohnen N. Chronic sequelae of herpes simplex encephalitis demonstrated on interictal F-18 FDG PET/CT. Clin Nucl Med 2008;33:443-444.
30. Hubele F, Bilger K, Kremer S, Imperiale A, Lioure B, Namer IJ. Sequential FDG PET and MRI findings in a case of human herpes virus 6 limbic encephalitis. Clin Nucl Med 2012;37:716-717.
31. Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci 2010;11:642-651.